CTLA4 and cardiomyopathy: A higher incidence of T cells expressing CTLA-4 among CD4+CD25− T cells from free/mild cardiomyopathy patients when compared to moderate/severe cardiomyopathy patients, also suggest a better negative control of the immune response, since CTLA-4 expression in CD25− T cells is known to suppress the immune response [40].